Coya Therapeutics, Inc.
General ticker "COYA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $100.7M (TTM average)
Coya Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -4.2%.
Estimated limits based on current volatility of 2.7%: low 4.59$, high 4.84$
Factors to consider:
- Total employees count: 6 as of 2022
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.53$, 7.95$]
- 2025-12-31 to 2026-12-31 estimated range: [3.12$, 7.13$]
Financial Metrics affecting the COYA estimates:
- Positive: with PPE of -5.6 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -12.33 <= 0.06
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of -0.03 > -0.64
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term COYA quotes
Long-term COYA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $6.00MM | $3.55MM |
| Operating Expenses | $9.81MM | $13.91MM | $20.80MM |
| Operating Income | $-9.81MM | $-7.90MM | $-17.25MM |
| Non-Operating Income | $-2.43MM | $0.64MM | $1.65MM |
| R&D Expense | $4.94MM | $6.04MM | $11.89MM |
| Income(Loss) | $-12.24MM | $-7.26MM | $-15.60MM |
| Taxes | $0.00MM | $0.72MM | $-0.72MM |
| Profit(Loss)* | $-12.24MM | $-7.99MM | $-14.88MM |
| Stockholders Equity | $-8.39MM | $35.64MM | $39.58MM |
| Assets | $8.40MM | $41.26MM | $44.35MM |
| Operating Cash Flow | $-7.24MM | $-11.19MM | $-10.29MM |
| Investing Cash Flow | $-0.53MM | $-0.54MM | $-0.03MM |
| Financing Cash Flow | $9.36MM | $38.43MM | $16.03MM |
| Earnings Per Share** | $-1.23 | $-0.79 | $-0.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.